The use of human immunodeficiency virus resistance tests in clinical practice.

doi:10.1111/j.1469-0691.2010.03353.x

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Back to search

Article

The use of human immunodeficiency virus resistance tests in clinical practice.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases - 1 Oct 2010

Ceccherini-Silberstein F, Cento V, Calvez V, Perno C-F

Abstract excerpt

Important progress has been made in recent years in the development and clinical use of drugs for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Nevertheless, when antiretroviral therapy fails to be fully suppressive, new viral variants emerge, thus allowing HIV-1 to escape from drug pressure by accumulating mutations. Between 50% and 70% of treated patients with virological rebound...

Topics

Anti-HIV Agents
Drug Monitoring
Drug Resistance, Viral
Genotype
HIV
HIV Infections
HIV-1
Humans
Microbial Sensitivity Tests
Practice Guidelines as Topic
Viral Proteins

Source

Open in PubMed

Identifiers

PMID: 20731678
DOI: 10.1111/j.1469-0691.2010.03353.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

discussions

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics